Vulcan Energy (ASX: VUL) Completes €100m Placement for Lionheart Project
Vulcan Energy completes a €100m placement to fund its transformative Lionheart Project, enhancing its lithium and renewable energy initiatives.
Category: Healthcare
Vulcan Energy (ASX: VUL) Secures EIB Financing Approval
Vulcan Energy secures EIB Board approval for up to €500 million funding for its lithium project in Germany.
BCAL Diagnostics Limited (ASX:BDX) Achieves NATA Accreditation
BCAL Diagnostics has achieved NATA accreditation and is on track to launch its BREASTEST® product in 2025.
Syntara Ltd (ASX:SNT) Secures A$15 Million Placement
Syntara Ltd raises A$15 million through a share placement to fund its clinical trials and strengthen its financial position.
Syntara Limited (ASX:SNT) Announces $15 Million Equity Raising
Syntara Limited (ASX:SNT) announces a $15 million equity placement to fund its clinical trial programs, primarily focusing on SNT-5505.
Aldoro Resources Limited (ASX:ARN) Confirms Niobium Mineralisation
Aldoro Resources (ASX:ARN) confirms significant niobium mineralisation at Kameelburg, marking a strong continued exploration effort.
Immutep Limited (ASX:IMM) Reports Promising Clinical Data
Immutep Limited (ASX:IMM) reveals promising data for HNSCC from the TACTI-003 trial, suggesting an effective therapy for underserved patients.
Orthocell Limited (ASX:OCC) Achieves First Sales of Remplir™
Orthocell Limited reports first sales of Remplir™ in Singapore, ahead of schedule, highlighting a strong start for its commercialisation strategy.
Cynata Therapeutics Limited (ASX:CYP) Treats First Patient in Kidney Transplant Trial
Cynata Therapeutics (ASX:CYP) has successfully treated its first patient in a kidney transplant clinical trial with CYP-001.
Vinyl Group (ASX:VNL) to Acquire Concrete Playground
Vinyl Group (ASX:VNL) has announced their acquisition of Concrete Playground for $5 million, enhancing their EBITDA and accelerating cash flow.